Angel R. Nebreda

The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona)

Parc Científic de Barcelona

C/ Baldiri Reixac 10

Barcelona, 08028

Spain

Catalan Institution of Research and Advanced Studies (ICREA)

Barcelona, 08010

Spain

SCHOLARLY PAPERS

2

DOWNLOADS

14

CITATIONS

0

Scholarly Papers (2)

1.

Optimal Linker Length for Small Molecule PROTACs that Selectively Target P38α and P38β for Degradation

CELL-CHEMICAL-BIOLOGY-D-19-00216
Number of pages: 50 Posted: 03 Jul 2019
The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona) and The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona)
Downloads 7 (593,053)

Abstract:

Loading...

Azide-alkyne click reaction, Cereblon, p38 MAPK, PROTAC linker optimization, Protein degradation, Thalidomide derivative

2.

Iκbα Deficiency Imposes a Fetal Phenotype to Intestinal Stem Cells

CELL-STEM-CELL-D-19-00327
Number of pages: 50 Posted: 18 May 2019
Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, University of Wisconsin - Madison - McArdle Laboratory of Cancer Research, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Department of Pathology, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Department of Pathology, The Barcelona Institute of Science and Technology (BIST) - Institute for Research in Biomedicine (IRB Barcelona), University of Wisconsin - Madison - McArdle Laboratory of Cancer Research, Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC and Autonomous University of Barcelona, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Cancer Research Program, CIBERONC
Downloads 7 (593,053)

Abstract:

Loading...

intestinal stem cells, regeneration, fetal-like conversion, nuclear IkappaB, polycomb